Keyword

Spinraza

Description: A brand name for nusinersen, an antisense oligonucleotide medicine used to treat spinal muscular atrophy.
OpenAlex ID: keywords/spinraza
2017 · David R Corey · Nature Neuroscience · 253
2017 · Eric W. Ottesen · Translational Neuroscience · 187
2022 · John W. Day, Kelly Howell, et al. · BMC Pediatrics · 166
2017 · Jennifer N. Kraszewski, Denise M. Kay, et al. · Genetics in Medicine · 160
2023 · Aladdin Y. Shchaslyvyi, Svitlana V. Antonenko, et al. · Pharmaceuticals · 128
2018 · Dunhui Li, Frank L. Mastaglia, et al. · Trends in Pharmacological Sciences · 80
2023 · Ioannis Papaioannou, James S. Owen, et al. · International Journal of Experimental Pathology · 71
2017 · V Prakash · Gene Therapy · 50
2018 · Michelle Pacione, Carly E. Siskind, et al. · Journal of Neuromuscular Diseases · 49
2020 · Xiang Lin, Haizhu Chen, et al. · Cell Research · 45
2017 · N M P King, C E Bishop · Gene Therapy · 40
2021 · Sarah Wadmann, Amalie Martinus Hauge · Social Studies of Science · 39
2020 · Ravindra N. Singh, Joonbae Seo, et al. · Expert Opinion on Therapeutic Targets · 30
2020 · Alexander A. Iyer, Julie R. Barzilay, et al. · Genetics in Medicine · 24
2021 · Mei W. Baker, Sean T. Mochal, et al. · Neuromuscular Disorders · 22
2022 · Sylwia Studzińska, Maria Mazurkiewicz-Bełdzińska, et al. · International Journal of Molecular Sciences · 17
2020 · Sabrina B. Frederiksen, Lise L. Holm, et al. · Human Mutation · 17
2019 · Lindsay N Alfano, Natalie F Miller, et al. · Developmental Medicine & Child Neurology · 16
2020 · Maaike van Putten, Julija Hmeljak, et al. · Disease Models & Mechanisms · 14
2020 · Mark Nuijten, Stefano Capri · Journal of Market Access & Health Policy · 14
2017 · J Glascock, M Lenz, et al. · Gene Therapy · 14
2021 · Mark Nuijten, Philippe Van Wilder · BMC Health Services Research · 13
Works count: 169
Citation count: 1,680
Year
Topic
Type